{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:48:32Z","timestamp":1772923712988,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,4,29]],"date-time":"2005-04-29T00:00:00Z","timestamp":1114732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,4,29]],"date-time":"2005-04-29T00:00:00Z","timestamp":1114732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>In order to use the results of a randomised trial, it is necessary to understand whether the overall observed benefit or harm applies to all individuals, or whether some subgroups receive more benefit or harm than others. This decision is commonly guided by a statistical test for interaction. However, with binary outcomes, different effect measures yield different interaction tests. For example, the UK Hip trial explored the impact of ultrasound of infants with suspected hip dysplasia on the occurrence of subsequent hip treatment. Risk ratios were similar between subgroups defined by level of clinical suspicion (P = 0.14), but odds ratios and risk differences differed strongly between subgroups (P &lt; 0.001).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Discussion<\/jats:title>\n                        <jats:p>Interaction tests on different effect measures differ because they test different null hypotheses. A graphical technique demonstrates that the difference arises when the subgroup risks differ markedly. We consider that the test of interaction acts as a check on the applicability of the trial results to all included subgroups. The test of interaction should therefore be applied to the effect measure which is least likely <jats:italic>a priori<\/jats:italic> to exhibit an interaction. We give examples of how this might be done.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Summary<\/jats:title>\n                        <jats:p>The choice of interaction test is especially important when the risk of a binary outcome varies widely between subgroups. The interaction test should be pre-specified and should be guided by clinical knowledge.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2288-5-15","type":"journal-article","created":{"date-parts":[[2005,5,3]],"date-time":"2005-05-03T18:24:57Z","timestamp":1115144697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Assessing subgroup effects with binary data: can the use of different effect measures lead to different conclusions?"],"prefix":"10.1186","volume":"5","author":[{"given":"Ian R","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Elbourne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,29]]},"reference":[{"key":"103_CR1","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0140-6736(00)02039-0","volume":"355","author":"SF Assmann","year":"2000","unstructured":"Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000, 355: 1064-1069. 10.1016\/S0140-6736(00)02039-0.","journal-title":"Lancet"},{"key":"103_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/jama.1991.03470010097038","volume":"266","author":"S Yusuf","year":"1991","unstructured":"Yusuf S, Wittes J, Probstfield J, Tyroler HA: Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. Journal of the American Medical Association. 1991, 266: 93-98. 10.1001\/jama.266.1.93.","journal-title":"Journal of the American Medical Association"},{"key":"103_CR3","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0895-4356(00)00210-9","volume":"53","author":"SD Walter","year":"2000","unstructured":"Walter SD: Choice of effect measure for epidemiological data. Journal of Clinical Epidemiology. 2000, 53: 931-9. 10.1016\/S0895-4356(00)00210-9.","journal-title":"Journal of Clinical Epidemiology"},{"key":"103_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","volume":"310","author":"RJ Cook","year":"1995","unstructured":"Cook RJ, Sackett DL: The number needed to treat: a clinically useful measure of treatment effect. British Medical Journal. 1995, 310: 452-4.","journal-title":"British Medical Journal"},{"key":"103_CR5","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/bmj.317.7168.1318","volume":"317","author":"DG Altman","year":"1998","unstructured":"Altman DG, Deeks JJ, Sackett DL: Odds ratios should be avoided when events are common. British Medical Journal. 1998, 317: 1318-","journal-title":"British Medical Journal"},{"key":"103_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/1403235","volume":"52","author":"DR Cox","year":"1984","unstructured":"Cox DR: Interaction. International Statistical Review. 1984, 52: 1-31.","journal-title":"International Statistical Review"},{"key":"103_CR7","volume-title":"British Medical Journal","author":"S Senn","year":"1999","unstructured":"Senn S: Rare Distinction and Common Fallacy. British Medical Journal. 1999, accessed 9 August 2004, [http:\/\/bmj.bmjjournals.com\/cgi\/eletters\/317\/7168\/1318]"},{"key":"103_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/ije\/31.1.72","volume":"31","author":"T Furukawa","year":"2002","unstructured":"Furukawa T, Guyatt G, Griffith L: Can we individualize the \"number needed to treat\"? An empirical study of summary effect measures in meta-analyses. International Journal of Epidemiology. 2002, 31: 72-76. 10.1093\/ije\/31.1.72.","journal-title":"International Journal of Epidemiology"},{"key":"103_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/bmj.313.7055.486","volume":"313","author":"DG Altman","year":"1996","unstructured":"Altman DG, Matthews JNS: Interaction 1: Heterogeneity of effects. British Medical Journal. 1996, 313: 486-","journal-title":"British Medical Journal"},{"key":"103_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/bmj.313.7060.808","volume":"313","author":"JNS Matthews","year":"1996","unstructured":"Matthews JNS, Altman DG: Interaction 2: Compare effect sizes not P values. British Medical Journal. 1996, 313: 808-","journal-title":"British Medical Journal"},{"key":"103_CR11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/bmj.313.7061.862","volume":"313","author":"JNS Matthews","year":"1996","unstructured":"Matthews JNS, Altman DG: Interaction 3: How to examine heterogeneity. British Medical Journal. 1996, 313: 862-","journal-title":"British Medical Journal"},{"key":"103_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","volume":"326","author":"DG Altman","year":"2003","unstructured":"Altman DG, Bland JM: Statistics Notes: Interaction revisited: the difference between two estimates. British Medical Journal. 2003, 326: 219-","journal-title":"British Medical Journal"},{"key":"103_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","volume":"116","author":"AD Oxman","year":"1992","unstructured":"Oxman AD, Guyatt GH: A consumer's guide to subgroup analysis. Annals of Internal Medicine. 1992, 116: 78-84.","journal-title":"Annals of Internal Medicine"},{"key":"103_CR14","first-page":"867","volume-title":"Treatment of Cancer","author":"R Peto","year":"1982","unstructured":"Peto R: Statistical aspects of cancer trials. Treatment of Cancer. Edited by: Halnan KE. 1982, London:Chapman and Hall, 867-871."},{"key":"103_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","volume":"361","author":"J Cuzick","year":"2003","unstructured":"Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P: Overview of the main outcomes in breast-cancer prevention trials. Lancet. 2003, 361: 296-300. 10.1016\/S0140-6736(03)12342-2.","journal-title":"Lancet"},{"key":"103_CR16","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/sim.1188","volume":"21","author":"JJ Deeks","year":"2002","unstructured":"Deeks JJ: Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine. 2002, 21: 1575-1600. 10.1002\/sim.1188.","journal-title":"Statistics in Medicine"},{"key":"103_CR17","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/S0140-6736(02)12024-1","volume":"360","author":"D Elbourne","year":"2002","unstructured":"Elbourne D, et al: Ultrasonography in the diagnosis and management of developmental hip dysplasia (UK Hip trial). Lancet. 2002, 360: 2009-2017. 10.1016\/S0140-6736(02)12024-1.","journal-title":"Lancet"},{"key":"103_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/eurpub\/7.1.101","volume":"7","author":"F Javier Jimenez","year":"1997","unstructured":"Javier Jimenez F, Guallar E, Martin-Moreno JM: A graphical display useful for meta-analysis. Eur J Public Health. 1997, 7: 101-105. 10.1093\/eurpub\/7.1.101.","journal-title":"Eur J Public Health"},{"key":"103_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1177\/009286150103500430","volume":"35","author":"DV Mehrotra","year":"2001","unstructured":"Mehrotra DV: Stratification issues with binary endpoints. Drug Information Journal. 2001, 35: 1343-1350.","journal-title":"Drug Information Journal"},{"key":"103_CR20","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF: What's the relative risk? A method of correcting the odds ratio on cohort studies of common outcomes. Journal of the American Medical Association. 1998, 280: 1690-1. 10.1001\/jama.280.19.1690.","journal-title":"Journal of the American Medical Association"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-5-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-2288-5-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-5-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-5-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:14:47Z","timestamp":1728306887000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/1471-2288-5-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,29]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1186\/1471-2288-5-15","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,29]]},"assertion":[{"value":"13 December 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}